Christopher C. Canale, M.D. – FDA 483, Aug 2, 2019
An FDA inspection of Wasatch Access Research LLC in Salt Lake City, UT, revealed significant deficiencies in the conduct of clinical investigations and the maintenance of adequate case histories. The firm failed to ensure investigations adhered to the investigational plan, with instances of falsified source documents by staff that went undetected by the Principal Investigator for an extended period. Additionally, critical original source documents for a study subject were missing and unrecoverable, indicating serious issues with data integrity and oversight of clinical trials.
ID · 77127a76-6e4a-4ebd-8112-96a52a144656
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.